Oregon Public Employees Retirement Fund’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.8M | Sell |
|
|||||
|
2025
Q2 | $2.54M | Hold |
|
|||||
|
2025
Q1 | $2.24M | Sell |
|
|||||
|
2024
Q4 | $2.82M | Buy |
|
|||||
|
2024
Q3 | $2.36M | Sell |
|
|||||
|
2024
Q2 | $2.88M | Sell |
|
|||||
|
2024
Q1 | $3.39M | Sell |
|
|||||
|
2023
Q4 | $3.66M | Buy |
|
|||||
|
2023
Q3 | $3.09M | Sell |
|
|||||
|
2023
Q2 | $2.66M | Sell |
|
|||||
|
2023
Q1 | $4.19M | Buy |
|
|||||
|
2022
Q4 | $4.94M | Buy |
|
|||||
|
2022
Q3 | $2.96M | Buy |
|
|||||
|
2022
Q2 | $2.67M | Sell |
|
|||||
|
2022
Q1 | $2.85M | Sell |
|
|||||
|
2021
Q4 | $2.64M | Sell |
|
|||||
|
2021
Q3 | $3.05M | Sell |
|
|||||
|
2021
Q2 | $3.14M | Buy |
|
|||||
|
2021
Q1 | $3.05M | Buy |
|
|||||
|
2020
Q4 | $85K | Sell |
|
|||||
|
2020
Q3 | $884K | Sell |
|
|||||
|
2020
Q2 | $1.19M | Buy |
|